Zinzino AB announced its preliminary sales results for the month of January 2026. Revenue during the month for Zinzino’s markets grew by 20%, totaling $30 million. The Faun Pharma external sales segment also experienced growth, totaling $786,000. Overall, group revenue reached $31 million.
South America, which includes Peru and Colombia, saw the strongest growth (344%). North America, which includes Canada, US and Mexico, grew by 94%. All other markets, with the exception of East Europe (Czech Republic, Slovakia, Hungary, Poland, Romania) saw positive growth rates.
The post Zinzino Releases Preliminary January 2026 Sales Report first appeared on Direct Selling News.
